Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lorazepam-efficacy, side effects, and rebound phenomena.

M B Scharf, A Kales, E O Bixler

    Clinical Pharmacology and Therapeutics
    |February 1, 1982
    PubMed
    Summary

    Four milligrams of lorazepam effectively improved sleep in insomniacs, but caused significant side effects like hangover and amnesia. Withdrawal led to rebound insomnia and anxiety.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Childhood obesity, weight loss and developmental trajectories predict the persistence and remission of childhood sleep-disordered breathing.

    Pediatric obesity·2018
    Same author

    Neurocognitive and behavioral functioning in adolescents with sleep-disordered breathing: a population-based, dual-energy X-ray absorptiometry study.

    International journal of obesity (2005)·2017
    Same author

    The relative association of obstructive sleep apnea, obesity and excessive daytime sleepiness with incident depression: a longitudinal, population-based study.

    International journal of obesity (2005)·2016
    Same author

    Stability of Disruptive Mood Dysregulation Disorder Symptoms (Irritable-Angry Mood and Temper Outbursts) Throughout Childhood and Adolescence in a General Population Sample.

    Journal of abnormal child psychology·2015
    Same author

    Unveiling the longitudinal association between short sleep duration and the incidence of obesity: the Penn State Cohort.

    International journal of obesity (2005)·2013
    Same author

    A reassessment of triazolam.

    The International journal of risk & safety in medicine·2013

    Area of Science:

    • Pharmacology
    • Sleep Medicine
    • Clinical Psychology

    Background:

    • Insomnia is a prevalent sleep disorder affecting millions globally.
    • Benzodiazepines, such as lorazepam, are commonly prescribed for sleep disturbances.
    • Understanding the efficacy and side effect profile of lorazepam is crucial for patient care.

    Purpose of the Study:

    • To evaluate the hypnotic effectiveness of 4 mg lorazepam in insomniac subjects.
    • To assess the effects of lorazepam on sleep stages and related parameters.
    • To investigate the occurrence of rebound insomnia and anxiety upon drug withdrawal.

    Main Methods:

    • An 18-night sleep-laboratory study was conducted with five insomniac subjects.
    • A placebo-controlled, within-subject design was employed.
    • Lorazepam (4 mg) was administered for seven nights, preceded and followed by placebo periods.

    Main Results:

    • Lorazepam significantly reduced sleep latency and total wake time (P < 0.01).
    • Rebound insomnia and increased sleep latency were observed during drug withdrawal (P < 0.01).
    • Significant side effects included hangover, impaired functioning, and anterograde amnesia.

    Conclusions:

    • Four milligrams of lorazepam demonstrates hypnotic efficacy in insomniacs.
    • Clinically significant side effects and rebound phenomena occur with this dosage.
    • Careful consideration of risks and benefits is warranted for lorazepam treatment.

    Related Experiment Videos